Related by context. All words. (Click for frequent words.) 78 Peg IFN 76 ribavirin RBV 76 pegylated interferon 74 dacarbazine 73 peginterferon 73 peginterferon alfa 2a 72 plus ribavirin 72 alfa 2a 72 telaprevir dosed 72 COPEGUS 72 peginterferon alfa 2b 71 pegylated interferon alpha 71 FOLFIRI 71 pegylated interferon alfa 2a 70 ribavirin therapy 70 pegylated interferon alfa 70 PegIFN RBV 70 PREZISTA r 70 LEXIVA r 70 Fludara 70 pegylated interferon alfa 2b 69 Pegasys ® 69 mcg kg 69 pegylated interferon peg IFN 69 docetaxel chemotherapy 69 INTELENCE 69 APTIVUS r 69 HCV RESPOND 2 69 nitazoxanide 69 chlorambucil 69 CIMZIA TM 69 lopinavir r 68 ritonavir boosted 68 abacavir lamivudine 68 peginterferon alfa 68 FOLFOX 68 interferon alfa 68 interferon alfa 2b 68 TNF inhibitor 68 PegIFN 68 PEGINTRON 68 carboplatin paclitaxel 68 peg interferon 68 administered subcutaneously 68 sustained virologic response 68 ELOXATIN 68 azathioprine 68 Pegasys plus Copegus 68 plus prednisone 67 ribavirin 67 DOXIL 67 REBETOL 67 active comparator 67 mg QD 67 low dose cytarabine 67 plus dexamethasone 67 #mg QD [002] 67 mapatumumab 67 FOLFOX4 67 ritonavir boosted atazanavir 67 mg kg dose 67 bendamustine 67 CHOP chemotherapy 67 TORISEL 67 ISENTRESS 67 PEG Intron 67 valopicitabine 67 docetaxel 67 darunavir ritonavir 67 mg BID 67 5-FU/LV 67 virologic failure 67 8mg/kg 67 nab paclitaxel 67 Elitek 66 interferon alfa 2a 66 tenofovir emtricitabine 66 mcg dose 66 PEGINTRON TM 66 VELCADE melphalan 66 darunavir r 66 undetectable HCV RNA 66 monotherapy 66 raltegravir 66 pegylated alpha interferon 66 estramustine 66 idarubicin 66 ACTEMRA TM 66 gemcitabine carboplatin 66 Taxotere ® 66 dosing cohorts 66 oral rivaroxaban 66 pyrazinamide 66 lamivudine 66 saline placebo 66 PREZISTA rtv 65 docetaxel Taxotere ® 65 adalimumab 65 ABC/3TC 65 TDF FTC 65 infusional 5-FU/LV 65 entecavir 65 peginterferon alpha 2a 65 subcutaneous injections 65 Pegasys R 65 amoxicillin clavulanate 65 pomalidomide 65 posaconazole 65 anti TNF alpha 65 comparator arm 65 PEG interferon 65 PegIntron 65 dexamethasone 65 oral allopurinol 65 mcg doses 65 μg dose 65 COMBIVIR 65 mirtazapine 65 AZT zidovudine Retrovir 65 q8h 65 anthracycline taxane 65 mg RDEA# 65 R# #mg BID 65 trabectedin 65 SVR# 65 DMARDs 65 Aptivus ® 65 tipranavir 65 #mg BID [003] 65 pegylated liposomal doxorubicin 65 vinorelbine 65 standard chemotherapy regimen 65 weekly subcutaneous injections 65 alpha 2a 65 lenalidomide Revlimid R 65 #mg/m# [002] 65 ceftazidime 65 valacyclovir 65 capecitabine 65 visilizumab 65 adefovir 64 Copegus ribavirin 64 mg/m2 administered 64 placebo dexamethasone 64 infliximab 64 virus HCV protease inhibitor 64 PEGASYS ® 64 HCV SPRINT 64 PEG IFN 64 Copegus 64 temozolomide 64 rapid virologic response 64 dosage regimens 64 #mg q8h 64 sitagliptin 64 #mg BID [002] 64 fluoropyrimidine 64 irinotecan 64 q#h 64 viral kinetics 64 trastuzumab Herceptin R 64 sunitinib 64 protease inhibitor PI 64 topotecan 64 alpha 2b 64 BARACLUDE ® 64 Pegasys peginterferon alfa 2a 64 LPV r 64 bicalutamide 64 boosted protease inhibitor 64 plus gemcitabine 64 decitabine 64 APTIVUS 64 plus methotrexate 64 Doxil ® 64 SCH # 64 pegIFN 64 tocilizumab 64 FOLFOX6 64 HCV genotype 1 64 #mg/day [002] 64 lopinavir 64 cisplatin vinorelbine 64 mitoxantrone 64 docetaxel Taxotere R 64 telbivudine 64 DMARD 64 daunorubicin 64 Traficet EN 64 tolvaptan 64 cetuximab Erbitux ® 64 ascending doses 64 mcg albinterferon alfa 2b 64 pegylated interferon alpha 2a 64 TYKERB 64 goserelin 64 CANCIDAS 64 MabCampath 63 dose dexamethasone 63 lopinavir ritonavir 63 interferon therapy 63 peginterferon alfa 2a #KD 63 PEG Interferon alfa 63 mg dose 63 PEG INTRON 63 fluticasone 63 FOLFOX6 chemotherapy regimen 63 octreotide LAR 63 Gemzar ® 63 mycophenolate mofetil 63 Ribavirin 63 COPEGUS ribavirin 63 enfuvirtide 63 atazanavir ritonavir 63 FOLPI regimen 63 doxorubicin HCl liposome injection 63 paclitaxel carboplatin 63 paclitaxel Taxol 63 FOLPI 63 flutamide 63 #mg BID [001] 63 ribavirin USP 63 interferon ribavirin 63 bortezomib 63 amrubicin 63 doxorubicin cyclophosphamide 63 forodesine 63 dexamethasone Decadron 63 gemcitabine chemotherapy 63 achieved ACR# 63 Hypersensitivity reactions 63 nadolol 63 4mg/kg 63 rilpivirine 63 irbesartan 63 trastuzumab Herceptin ® 63 achieved sustained virologic 63 methotrexate MTX 63 biologic DMARD 63 piperacillin tazobactam 63 5 FU leucovorin 63 Folfox 63 dosing intervals 63 Allovectin 7 ® 63 insulin detemir 63 peginterferon alfa 2a Pegasys 63 Peginterferon 63 celgosivir 63 relapsed MM 63 DEB# 63 telaprevir VX 63 chronic HCV infection 63 JANUVIA 63 Xelox 63 pegylated interferons 63 VICTRELIS 63 evaluating tivozanib 63 abatacept 63 ritonavir boosted protease inhibitor 63 sorafenib Nexavar ® 63 tenofovir disoproxil fumarate 63 pertuzumab 63 infliximab monotherapy 63 certolizumab 63 sorafenib tablets 63 IV bolus 63 amphotericin B 63 carboplatin 63 palonosetron 63 Jevtana 63 intravenous bisphosphonates 63 TMC# [001] 63 oral ridaforolimus 63 vandetanib 63 mg/m2/day 63 ONGLYZA 63 clodronate 63 ZOLINZA 63 darunavir 63 Torisel 63 cisplatin gemcitabine 63 FluCAM 63 median PFS 63 Alkeran 63 PEG Intron ® 63 imatinib therapy 63 TNF antagonists 63 REBETOL combination therapy 63 Virologic 62 DMARDS 62 etravirine 62 pyridostigmine 62 triple nucleoside 62 AZILECT 62 Viread Emtriva 62 maximally tolerated dose 62 randomized #:#:# 62 null responders 62 #mg QD [001] 62 zidovudine lamivudine 62 aflibercept 62 leucovorin 62 NOXAFIL 62 lopinavir r arm 62 Capecitabine 62 relapsed myeloma 62 INFERGEN 62 ethambutol 62 mg eq 62 adalimumab Humira 62 dasatinib 62 cisplatin chemotherapy 62 febuxostat 62 mg ustekinumab 62 neurologic progression 62 RG# [001] 62 fluorouracil 62 plus COPEGUS 62 tipranavir ritonavir 62 treatment naïve genotype 62 intravitreal injection 62 #mg/m# [001] 62 baminercept 62 mg m² 62 5 fluorouracil 62 TELINTRA 62 NNRTI 62 Flu Cy 62 docetaxel Taxotere 62 null responder HCV 62 FROVA 62 metformin sulfonylurea 62 cyclophosphamide doxorubicin vincristine 62 oral diclofenac 62 XELOX 62 abiraterone acetate 62 virological failure 62 Irinotecan 62 Pemetrexed 62 tenofovir Viread 62 azacitidine 62 anthracyclines taxanes 62 HBeAg positive patients 62 metastatic RCC 62 oral levofloxacin 62 Pegintron 62 Pharmacokinetic parameters 62 fluvastatin 62 #mg dose [003] 62 metastatic HRPC 62 boceprevir 62 continuous intravenous infusion 62 Darunavir 62 Mylotarg 62 subcutaneously administered 62 dacarbazine DTIC 62 melphalan prednisone 62 stavudine d4T 62 gemcitabine Gemzar 62 Rebetol 62 cidofovir 62 Q2W 62 vicriviroc 62 refractory CLL 62 paliperidone ER 62 uric acid lowering 62 ATACAND 62 bevacizumab Avastin 62 gefitinib 62 NRTI 62 peginterferon ribavirin 62 teriflunomide 62 placebo intravenously 62 severe neutropenia 62 dose cytarabine 62 DMARD therapy 62 rituximab 62 temsirolimus 62 CCyR 62 TNF antagonist 62 CIMZIA ™ 62 adriamycin 62 5FU 62 amprenavir 62 dalteparin 62 chemotherapy gemcitabine 62 treatment naive genotype 62 KAPIDEX 62 lenalidomide dexamethasone 62 ZYVOX 62 erlotinib Tarceva ® 62 Certolizumab 62 HGS# 62 oral prednisone 62 chemoradiation 62 tipranavir r 62 doxorubicin docetaxel 62 Solid Tumors criteria 62 Navelbine ® 62 CAELYX 62 3mg/kg 62 KOMBIGLYZE XR 62 zileuton 62 docetaxel prednisone 62 alpha interferons 62 REMICADE ® 62 RoACTEMRA 62 postmenopausal osteoporotic women 62 antiandrogen 62 naïve HCV 62 disease modifying antirheumatic 62 ribavirin Copegus 62 Tamibarotene 62 NATRECOR ® 62 Clevudine 62 methotrexate monotherapy 62 sorafenib Nexavar 61 mg/m2 dose 61 achieve sustained virologic 61 DexaSite 61 Velcade bortezomib 61 allopurinol 61 antiretroviral naive 61 thymalfasin 61 PREZISTA ritonavir 61 telaprevir pegylated interferon 61 zonisamide SR 61 fludarabine 61 telaprevir 61 weekly intravenous infusions 61 mRCC 61 IIIa inhibitor 61 detectable HCV RNA 61 gemcitabine 61 HBeAg positive 61 PEGylated anti 61 primary hypercholesterolemia 61 MAGE A3 ASCI 61 mCRC patients 61 nelfinavir 61 telaprevir dosing 61 HAART regimens 61 log# IU mL 61 SPRYCEL ® 61 Taxotere R 61 albinterferon alfa 2b 61 Pegasys 61 EGFR expressing mCRC 61 imipenem 61 morphometric vertebral fractures 61 sustained virological response 61 alkylating agent 61 Peginterferon alfa 2a 61 R ribavirin USP 61 oxymorphone ER 61 refractory multiple myeloma 61 thalidomide Thalomid 61 #mg ATC 61 NRTIs 61 iniparib 61 PEG INTRON R 61 leflunomide 61 Omacetaxine mepesuccinate 61 TEMODAL 61 omega interferon 61 Engerix B 61 zidovudine 61 undetectable virus HCV 61 Platinol ® cisplatin 61 HIV RNA 61 steroid dexamethasone 61 mg TID 61 bevacizumab Avastin ® 61 romiplostim 61 Tarceva TM 61 Xeloda ® 61 paclitaxel Taxol ® 61 injected subcutaneously 61 novel VDA molecule 61 sorafenib 61 unfractionated heparin 61 blinded randomized placebo controlled 61 MGd 61 refractory NSCLC 61 doripenem 61 genotypic resistance 61 gemcitabine cisplatin 61 adefovir dipivoxil 61 virologic response 61 ARIKACE 61 anakinra 61 Hepsera 61 mcg QD 61 plus Copegus R 61 Amrubicin 61 glatiramer acetate 61 antiretroviral naïve 61 pemetrexed 61 FOLFOX4 alone 61 AZOR 61 APTIVUS ritonavir 61 patients evaluable 61 mitoxantrone chemotherapy 61 postoperative chemotherapy 61 concurrent chemoradiation 61 AIR CF1 61 zolmitriptan 61 NEUPOGEN 61 virologic responses 61 refractory chronic lymphocytic 61 zoledronic acid 61 chemoradiotherapy 61 NATRECOR R 61 efalizumab 61 Cladribine tablets 61 subcutaneous dose 61 ritonavir boosted lopinavir 61 lamivudine 3TC 61 plus prednisone prednisolone 61 desvenlafaxine succinate 61 colesevelam HCl 61 budesonide pMDI 61 REYATAZ R 61 efavirenz EFV 61 3TC lamivudine Epivir 61 metastatic renal cell carcinoma 61 fosamprenavir 61 oral ribavirin 61 tinidazole 61 cyclophosphamide methotrexate 61 MIRCERA 61 HGS ETR1 61 remission induction 61 Sandostatin LAR 61 relapsed refractory multiple myeloma 61 azacytidine 61 PEG Interferon lambda 61 galiximab 61 rFVIIa 61 Pegylated Interferon 61 dose titration 61 lispro 61 Imprime PGG 61 administered concomitantly 61 NXL# 61 mg/m2 IV 61 relapsed multiple myeloma 61 COPAXONE R 61 #mg/kg [002] 61 voriconazole 61 cytotoxic therapy 61 oxycodone CR 61 Peg riba 61 ULORIC 61 PD LID 61 placebo controlled trials 61 #mg dose [001] 61 mg simvastatin 61 ascending dose 61 partial remissions 61 ALT flares 61 LEXIVA 61 Hycamtin ® 61 receiving INTRON 61 metformin HCl 61 bortezomib Velcade 61 INC# 61 antiviral efficacy 61 YONDELIS 61 cytarabine daunorubicin 61 recurrent genital herpes 61 elotuzumab 61 diuretic chlorthalidone 61 HGS ETR1 mapatumumab 61 OADs 61 serum phosphorus 61 glucose lowering 61 undetectable viral load 61 #mg dose [002] 61 dose cohort 61 INCB# [001] 61 PREZISTA 61 microbiological eradication 61 virological response 61 apremilast 60 acute gout flares 60 PASI scores 60 Ceplene/IL-2 60 antiretroviral regimen 60 oral prodrug 60 ACTEMRA 60 fasting plasma glucose FPG 60 nilotinib 60 NRTI backbone 60 CRESTOR #mg 60 BARACLUDE R 60 salmeterol fluticasone 60 divalproex sodium 60 pegylated interferon ribavirin 60 antimuscarinic 60 microgram doses 60 efavirenz emtricitabine 60 Bezielle 60 bevacizumab 60 AGILECT ® 60 rizatriptan 60 investigational protease inhibitor 60 GnRH agonist 60 evaluable 60 #mg/day [001] 60 induction regimen 60 rilonacept 60 BoNTA 60 nucleoside reverse transcriptase inhibitor 60 etanercept 60 mcg Albuferon 60 Copegus ® ribavirin 60 IFN alfa 60 idraparinux 60 sipuleucel T 60 Camptosar ® 60 REVLIMID ® 60 Raptiva ® 60 cobicistat 60 TYGACIL 60 oral antidiabetic agents 60 VFEND 60 Vectibix 60 FIRMAGON 60 Topotecan 60 dacetuzumab 60 taxane chemotherapy 60 Herceptin trastuzumab 60 mcg BID 60 dose regimens 60 mitoxantrone plus 60 hypomethylating agents 60 NPH insulin 60 CIMZIA TM certolizumab pegol 60 triamcinolone 60 RECIST Response Evaluation Criteria 60 alteplase 60 IFN α 60 Dacogen injection 60 mg/m2 60 TRIZIVIR 60 Response Evaluation Criteria 60 Telintra 60 DOXIL ® 60 Tasigna nilotinib 60 fluconazole 60 pamidronate 60 log# reduction 60 mg qd 60 Peginterferon alfa 2b 60 interferon gamma 1b 60 palifermin 60 G CSF 60 beta2 agonist 60 receiving VICTRELIS 60 ARB telmisartan 60 urate lowering therapy 60 #.#mg/dL 60 sevelamer 60 chemoradiation therapy 60 Bortezomib 60 patients coinfected 60 ceftriaxone 60 randomized #:# 60 Proellex TM 60 TMC# r 60 oral anticoagulant 60 Fludara ® 60 intramuscularly 60 paliperidone palmitate 60 granisetron 60 Peginterferon Alfa 2a 60 recurrent glioblastoma multiforme 60 Aflibercept 60 etoposide 60 daptomycin 60 metastatic SCCHN 60 dasatinib Sprycel ® 60 ALGRX 60 indinavir 60 gadobutrol 60 rhGH 60 BEACOPP 60 golimumab 60 Doxil 60 riociguat 60 REYATAZ r 60 metastatic CRC 60 GSK# [001] 60 plus MTX 60 rituximab Rituxan ® 60 CRp 60 Seliciclib 60 Lamivudine 60 vismodegib 60 SAR# [004] 60 mg/# hr 60 standard chemotherapy regimens 60 SELZENTRY 60 OncoVEX GM CSF 60 motesanib 60 VIRAMUNE XR 60 serum urate 60 glycoprotein IIb IIIa inhibitor 60 saquinavir ritonavir 60 AzaSite Plus 60 Copegus ® 60 Lamictal XR 60 β blockers 60 rosuvastatin #mg 60 metaglidasen 60 TNF inhibitors 60 chemotherapy docetaxel 60 oral deforolimus 60 seroprotection 60 symptomatic BPH 60 HGS ETR2 60 renal toxicity 60 lopinavir ritonavir Kaletra 60 irinotecan doxorubicin oxaliplatin paclitaxel 60 serum phosphorous 60 oral vancomycin 60 STELARA 60 NNRTIs 60 Dapagliflozin 60 ACE inhibitor ramipril 60 Raptiva r 60 Phe restricted diet 60 epirubicin cyclophosphamide 60 neratinib 60 HBeAg seroconversion 60 zafirlukast 60 low dose ritonavir 60 Gemcitabine 60 serum HCV RNA 60 anti TNF 60 placebo controlled clinical trials 60 RLAI 60 atazanavir 60 ancrod 60 methotrexate therapy 60 intravesical 60 RGT arm 60 CA4P 60 LIALDA 60 trastuzumab 60 nucleoside analog 60 pramlintide 60 atazanavir sulfate 60 CTAP# Capsules 60 mg q#h 60 aflibercept VEGF Trap 60 milligram doses 60 irinotecan chemotherapy 60 ACZ# 60 GnRH agonists 60 doxazosin 60 maximal tolerated 60 FOLFOX regimen 60 JANUMET 60 VIRAMUNE 60 tolterodine ER 60 fluticasone furoate 60 Panzem R NCD 60 ABRAXANE therapy 60 gout flares 60 BRIM2 60 non squamous NSCLC 60 gemifloxacin 60 zidovudine AZT 60 recurrent GBM 60 ARCOXIA 60 TELCYTA 60 DAPT 59 Omacetaxine 59 intravenous bolus 59 basal insulin 59 montelukast 59 eplerenone 59 metastatic GIST 59 metreleptin 59 cetuximab 59 RAPTIVA 59 liposomal doxorubicin 59 statin monotherapy 59 darbepoetin alfa 59 inactive placebo 59 Pegylated Liposomal Doxorubicin 59 PROMACTA 59 pegylated 59 plasma HCV RNA 59 HBeAg negative 59 dosing cohort 59 Tekamlo 59 FOLFIRI alone 59 SIMPONI 59 intermittent dosing 59 antihypertensive agents 59 Mg Uk 59 atovaquone 59 evaluating Xcytrin 59 tamsulosin 59 antiplatelet agent 59 HuMax CD4 59 huN# DM1 59 BENICAR HCT 59 imatinib 59 canakinumab 59 STELARA TM 59 paclitaxel poliglumex 59 neoadjuvant chemotherapy 59 lapatinib 59 liposome injection 59 LANTUS R 59 REVLIMID lenalidomide 59 immunosuppressive agents 59 biologic therapy 59 LY# [003] 59 IMiDs ® 59 Primary endpoints 59 COPAXONE ® 59 aspirin clopidogrel 59 insulin lispro 59 mg q8h 59 metastatic colorectal carcinoma 59 #mg doses [002] 59 trials RCTs 59 potent CYP#A# inhibitors 59 cetuximab Erbitux R 59 PRT# 59 mg d 59 PSMA ADC 59 TAXOTERE R 59 cilengitide 59 Dasatinib 59 IXEMPRA 59 aliskiren 59 tacrolimus ointment 59 phase IIb clinical 59 prospectively defined 59 Tarceva erlotinib 59 tamoxifen therapy 59 zalutumumab 59 dose cohorts 59 fenofibric acid 59 Pegylated interferon 59 cisplatin 59 MYCAMINE 59 virologic 59 eribulin 59 eszopiclone 59 alpha interferon 59 aminotransferase elevations greater 59 Platinol ® 59 ziprasidone 59 inhaled corticosteroid ICS 59 tolterodine 59 conventional DMARDs 59 systemically administered 59 TREDAPTIVE 59 KRAS mutations occur 59 levosimendan 59 Cytoxan 59 FOLFOX chemotherapy 59 oral antidiabetic 59 nicardipine 59 5mg/kg 59 vapreotide acetate 59 EGFR TKI 59 lenalidomide 59 mesalamine granules 59 FOSRENOL ® 59 receiving prophylactic anticoagulation 59 ORENCIA ® 59 etanercept Enbrel 59 favorable pharmacokinetic profile 59 lixisenatide 59 octreotide acetate 59 rHuPH# 59 achieved PASI 59 hepatic metastases 59 cilostazol 59 statistically significant superiority 59 ertapenem 59 evaluable patients 59 FFNS 59 Pharmacokinetics PK 59 Bevacizumab 59 ixabepilone 59 Exforge HCT 59 ganciclovir 59 5 Fluorouracil 59 Epivir 59 chemotherapy regimen 59 moxifloxacin 59 leukemia CLL 59 milatuzumab 59 oral antidiabetic medication 59 Cayston 59 dosing regimens 59 Telbivudine 59 ibandronate 59 nevirapine Viramune 59 BMS # 59 MYDICAR ® 59 XGEVA 59 subcutaneous SC 59 neoadjuvant 59 Perforomist Inhalation Solution 59 metastatic hormone refractory 59 rFSH 59 cabazitaxel 59 Triapine R 59 coinfected patients 59 pemetrexed Alimta 59 relapsing multiple sclerosis 59 Sandostatin LAR Depot 59 cytarabine 59 Taxotere 59 anthracycline containing 59 miconazole 59 pimozide 59 levofloxacin 59 Ixempra 59 oral chemotherapeutic agent 59 HyQ 59 Trastuzumab 59 melphalan 59 clomipramine 59 tenofovir DF 59 cyclophosphamide chemotherapy 59 tiotropium 59 pharmacologically active isomer 59 Adalimumab 59 interferon alpha 59 erlotinib 59 macrolide antibiotic 59 Emtriva 59 naive HCV 59 inhalations twice 59 ALIMTA cisplatin 59 Victoza R 59 CCR5 tropic HIV 59 sulphonylureas 59 VELCADE 59 dapagliflozin plus 59 pharmacokinetic interactions 59 intravenous iv 59 Aptivus 59 certolizumab pegol 59 mertansine 59 GAMMAGARD 59 daily Infergen 59 anti EGFR antibody 59 antithymocyte globulin 59 evaluable subjects 59 pioglitazone HCl 59 severe hypersensitivity reactions 59 prednisone prednisolone plus 59 Xcytrin 59 Sprycel dasatinib 59 Epivir HBV 59 dose regimen 59 nucleoside analogs 59 relapsed ovarian cancer 59 dosage regimen 59 progression TTP 59 olmesartan 59 MoxDuo TM IR 59 rifapentine 59 BEXXAR 59 FUSILEV enhances 59 mGluR5 NAM 59 oral antiviral 59 RAPAFLO 59 transaminase elevations 59 Byetta exenatide 59 fondaparinux 59 CTA# Injection 59 subcutaneous doses 59 DAVANAT 59 Golimumab 59 Secondary endpoints 59 PEG SN# 59 cEVR 59 Eloxatin R 59 R sorafenib tablets 59 linezolid 59 dose dose escalation 59 invasive candidiasis 59 relapsing MS 59 intramuscular injections 59 oral FTY# 59 candesartan cilexetil